[Note the irritant effect of Emla® cream potentially leading to diagnostic errors].
Service de dermatologie, hôpital Brabois, bâtiment P.-Canton, Vandoeuvre-lès-Nancy, France. jl.schmutz@chu-nancy.fr
J-L
JL
Schmutz
P
P
Trechot
D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis; D017453:Dermatitis, Irritant / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D003937:Diagnosis, Differential; D004485:Eczema / Q000175:diagnosis; D004820:Epidermolysis Bullosa / Q000175:diagnosis; D005260:Female; D006801:Humans; D007223:Infant; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects*; D000077442:Lidocaine, Prilocaine Drug Combination; D009824:Ointments; D011318:Prilocaine / Q000008:administration & dosage / Q000009:adverse effects*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology
D000779:Anesthetics, Local; D000077442:Lidocaine, Prilocaine Drug Combination; D009824:Ointments; D011318:Prilocaine; D008012:Lidocaine